Current state and novel approaches of antiplatelet therapy

QR Code

Current state and novel approaches of antiplatelet therapy

An unresolved problem with clinical use of antiplatelet therapy is that a significant number of individuals either still get thrombosis or run the risk of life-threatening bleeding. Antiplatelet drugs are widely used clinically, either chronically for people at risk of athero/thrombotic disease or t...

Full description

Bibliographic Details
Main Authors:	Metharom, P., Berndt, Michael, Baker, R., Andrews, R.
Format:	Journal Article
Published:	Lippincott Williams and Wilkins 2015
Online Access:	http://hdl.handle.net/20.500.11937/27777

Similar Items

Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery disease
by: Peace, A., et al.
Published: (2008)

Antiplatelet therapy following ischaemic stroke: continue or change pre-existing therapy?
by: Mazlan-Kepli, Wardati, et al.
Published: (2017)

The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
by: Amin, Arwa M., et al.
Published: (2017)

Pretreatment with dual antiplatelet therapy in patients with ST-elevation myocardial infarction.
by: Yudi, M., et al.
Published: (2017)

A brief history of blood platelets: A personal view
by: Berndt, Michael, et al.
Published: (2017)

Primary haemostasis: Newer insights
by: Berndt, Michael, et al.
Published: (2014)

Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke
by: Hilkens, Nina A., et al.
Published: (2018)

Interruption to antiplatelet therapy early after acute ischaemic stroke: a nested case-control study
by: Mazlan-Kepli, Wardati, et al.
Published: (2017)

Antiplatelet activity should be measured routinely: no
by: Bath, Philip M.W.
Published: (2009)

Mechanism of action of antiplatelet drugs on decompression sickness in rats: A protective effect of anti-GPIIbIIIa therapy
by: Lambrechts, K., et al.
Published: (2015)

The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
by: Mostafa, Arwa Mohamed Amin
Published: (2016)

A randomised controlled trial of triple antiplatelet therapy (Aspirin, Clopidogrel and Dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility
by: Sprigg, Nikola, et al.
Published: (2008)

COMP: An endogenous thrombin inhibitor
by: Metharom, P., et al.
Published: (2015)

Predicting major bleeding in patients with noncardioembolic stroke on antiplatelets
by: Hilkens, Nina A., et al.
Published: (2017)

Effect of antiplatelet and/or anticoagulation medication on the risk of tympanic barotrauma in hyperbaric oxygen therapy patients and development of a predictive model.
by: Buzzacott, Peter, et al.
Published: (2020)

Antiplatelet therapy for secondary prevention in patients with ischaemic stroke and transient ischaemic attack: a retrospective cohort study in Malaysia
by: Ab Rahman N,, et al.
Published: (2023)

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)
by: Beridze, M., et al.
Published: (2015)

Pretreatment with Dual Antiplatelet Therapy in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention
by: Yudi, M., et al.
Published: (2015)

Thrombin-induced reactive oxygen species generation in platelets: A novel role for protease-activated receptor 4 and GPIba.
by: Carrim, N., et al.
Published: (2015)

Impact of Discontinuation of Antiplatelet Therapy Prior to Isolated Valve and Combined Coronary Artery Bypass Graft and Valve Procedures on Short and Intermediate Term Outcomes
by: Meneguzzi, J., et al.
Published: (2017)

Medicinal herbals with antiplatelet properties benefit in coronary atherothrombotic diseases
by: Mohd Nor, Nurul Huda, et al.
Published: (2016)

Bernard-Soulier Syndrome: An Update
by: Andrews, R., et al.
Published: (2013)

Liver-mediated shedding of platelet GPVI
by: Berndt, Michael, et al.
Published: (2016)

Microparticles facilitate neutrophil platelet crosstalk
by: Andrews, R., et al.
Published: (2008)

The GPIb-IX-V Complex
by: Andrews, R., et al.
Published: (2013)

Systems biology meets platelet biology
by: Berndt, Michael, et al.
Published: (2008)

Platelet-VWF complexes get the chop
by: Berndt, Michael, et al.
Published: (2008)

Mocarhagin
by: Andrews, R., et al.
Published: (2013)

Platelet adhesion: A game of catch and release
by: Andrews, R., et al.
Published: (2008)

Major Platelet Glycoproteins: GPIB-IX-V
by: Berndt, Michael, et al.
Published: (2013)

New direction for WE thrombin
by: Berndt, Michael, et al.
Published: (2008)

The functional role of platelets in the regulation of angiogenesis
by: Walsh, T., et al.
Published: (2015)

Anti-inflammatory and antiplatelet activities of plasma are conserved across twelve mammalian species
by: Ahmed, Sagheer, et al.
Published: (2014)

The History of Armand Trousseau and Cancer-Associated Thrombosis
by: Metharom, Pat, et al.
Published: (2019)

Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International clarify registry
by: Fauchier, L., et al.
Published: (2015)

Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial
by: Bath, Philip M.W., et al.
Published: (2015)

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
by: Bath, Philip M.W., et al.
Published: (2018)

Editorial: Platelet hem-Immunoreceptor Tyrosine-Based Activation Motif Receptors: At Lease One Required
by: Berndt, Michael, et al.
Published: (2013)

Functional association of phosphoinositide-3-kinase with platelet glycoprotein Iba, the major ligand-binding subunit of the glycoprotein Ib-IX-V complex
by: Mu, F., et al.
Published: (2010)

Review on the current state of diacylglycerol production using enzymatic approach
by: Eng, Tong Phuah, et al.
Published: (2015)